Nephrology Doctors in Providence, RI Accepting Medicare

7 Nephrology doctors found. Showing 1 - 7

Edward Medeiros, DO Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1076 N Main St, Providence, RI 02904 Phone: 401-861-7711    Fax: 401-421-5710

David C Yoburn, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1076 N Main St, Providence, RI 02904 Phone: 401-861-7711    Fax: 401-421-5710

Katherine Davoren, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1076 N Main St, Providence, RI 02904 Phone: 401-861-7711    Fax: 401-421-5710

Ayman M. Wahbeh, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Middle House 3, Providence, RI 02903 Phone: 401-444-5445    Fax: 401-444-6849

Dr. Marc S Weinberg, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Randall Sq Ste 304, Providence, RI 02904 Phone: 401-228-3000    Fax: 401-649-4222

Dr. Keith R Bartolomei, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1076 N Main St, Providence, RI 02904 Phone: 401-861-7711    Fax: 401-421-5710

Andrew J. Cohen, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Apc 9, Providence, RI 02903 Phone: 401-444-5445    Fax: 401-444-8453

News Archive

Results of Phase IIb dose range finding of oglemilast in chronic obstructive pulmonary disease announced

Forest Laboratories, Inc. (NYSE: FRX) and Glenmark Pharmaceuticals S.A. (Switzerland), a wholly owned subsidiary of Glenmark Pharmaceuticals India (GPL) today announced top-line results from a Phase IIb dose range-finding study of oglemilast in patients with Chronic Obstructive Pulmonary Disease (COPD). Once-daily treatment with oglemilast did not show a statistically meaningful increase from baseline compared to placebo in the primary endpoint trough FEV1, a measure of pulmonary function that is decreased in patients with COPD. Oglemilast was well tolerated at all doses studied.

Botox effect modest in migraine prevention: Study

Botox injections have been used in prevention of migraines but new research shows that its effect is only modest. Among chronic sufferers who had at least 15 migraines a month, the treatment prevented, on average, about two headaches a month. Botox was no more effective than some of the most widely prescribed drugs used for migraines when the treatments were compared.

Modular gene enhancers may be suitable target in treatment of blood cancer

Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer.

Eating egg yolks accelerates atherosclerosis in a manner similar to smoking

Newly published research led by Dr. David Spence of Western University, Canada, shows that eating egg yolks accelerates atherosclerosis in a manner similar to smoking cigarettes.

Read more Medical News

› Verified 9 days ago